Enhancing NSCLC Neoadjuvant Therapy : vimarsana.com

A panel deliberates post-neoadjuvant strategies and data requirements for optimizing immune checkpoint inhibitors in NSCLC neoadjuvant therapy.

Related Keywords

Spain , David Carbone , Martin Dietrich , Patrick Forde , , Nsclc , Non Small Cell Lung Cancer , Neoadjuvant , Advanced Disease , Early Stage Disease , Post Op Setting , Novel Agent , Targeted Therapy , Immunotherapy , Trio Therapy ,